[HTML][HTML] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness… - Journal of Intensive …, 2018 - Springer
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk… - … of intensive care, 2018 - pubmed.ncbi.nlm.nih.gov
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness, SJ Seyler… - tspace.library.utoronto.ca
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness… - Journal of Intensive …, 2018 - search.proquest.com
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

[PDF][PDF] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness, SJ Seyler - 2018 - scholar.archive.org
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS.

GU Meduri, RAC Siemieniuk, RA Ness… - Journal of Intensive …, 2018 - europepmc.org
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

[HTML][HTML] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk… - Journal of …, 2018 - jintensivecare.biomedcentral.com
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

[HTML][HTML] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness… - Journal of Intensive …, 2018 - ncbi.nlm.nih.gov
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …

[引用][C] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness… - Journal of Intensive …, 2018 - cir.nii.ac.jp
Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of
mechanical ventilation and mortality in patients with ARDS | CiNii Research CiNii 国立情報学 …

[PDF][PDF] Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS

GU Meduri, RAC Siemieniuk, RA Ness, SJ Seyler - 2018 - academia.edu
An updated meta-analysis incorporating nine randomized trials (n= 816) investigating low-to-
moderate dose prolonged glucocorticoid treatment in acute respiratory distress syndrome …